BioSpace News Archive

Pomerantz LLP announces that a class action lawsuit has been filed against Aveo Pharmaceuticals, Inc. and certain of its officers and directors.

Pomerantz LLP announces that a class action lawsuit has been filed against Inogen, Inc. and certain of its officers and directors.

Pomerantz LLP announces that a class action lawsuit has been filed against Akorn, Inc. and certain of its officers and directors.

Judge Richard J. Leon of the U.S. District Court for the District of Columbia ruled Monday that AIDS Healthcare Foundation (AHF) may propose up to three witnesses to testify at an upcoming evidentiary hearing in opposition to the nearly $70 billion acquisition of Aetna by CVS Health Corp.

Stress creates risk, maternal education provides resilience

Pomerantz LLP announces that a class action lawsuit has been filed against Weight Watchers International, Inc. and certain of its officers and directors.

Company Believes U.S. Justice Department Is Fundamentally Wrong, Will Contest Charges Vigorously

Pomerantz LLP announces that a class action lawsuit has been filed on behalf of investors in Synergy Pharmaceutical, Inc. against certain of the Company’s current and former officers and directors.

Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Dr Gillies O’Bryan-Tear has joined Clarity’s Board following his recent appointment to their Scientific Advisory Board in August 2018.

Children’s Hospital of Philadelphia (CHOP) announced today that Beverly L. Davidson, PhD, CHOP’s Chief Scientific Strategy Officer and Director of the Raymond G. Perelman Center for Cellular and Molecular Therapeutics, has been elected Vice President of the Board of Directors for the American Society of Gene and Cell Therapy (ASGCT), the largest association of individuals involved in gene and cell therapy research.